Mammalian telomeric DNA suppresses endotoxin-induced uveitis

dc.citation.epage28811en_US
dc.citation.issueNumber37en_US
dc.citation.spage28806en_US
dc.citation.volumeNumber285en_US
dc.contributor.authorYagci, F. C.en_US
dc.contributor.authorAslan, O.en_US
dc.contributor.authorGursel, M.en_US
dc.contributor.authorTincer, G.en_US
dc.contributor.authorÖzdamar, Y.en_US
dc.contributor.authorKaratepe, K.en_US
dc.contributor.authorAkcali, K. C.en_US
dc.contributor.authorGursel, I.en_US
dc.date.accessioned2016-02-08T09:57:03Z
dc.date.available2016-02-08T09:57:03Z
dc.date.issued2010en_US
dc.departmentDepartment of Molecular Biology and Geneticsen_US
dc.description.abstractTelomeric regions of mammalian chromosomes contain suppressive TTAGGG motifs that inhibit several proinflammatory and Th1-biased immune responses. Synthetic oligodeoxynucleotides (ODN) expressing suppressive motifs can reproduce the down-regulatory activity of mammalian telomeric repeats and have proven effective in the prevention and treatment of several autoimmune and autoinflammatory diseases. Endotoxin-induced uveitis (EIU) is an established animal model of acute ocular inflammation induced by LPS administration. Augmented expression of proinflammatory cytokines/chemokines such as TNFα, IL-6, and MCP1 and bactericidal nitric oxide production mediated by LPS contribute to the development of EIU. Suppressing these mediators using agents that are devoid of undesirable systemic side effects may help prevent the development of EIU. This study demonstrates the selective down-regulatory role of suppressive ODN after (i) local or (ii) systemic treatment in EIU-induced rabbits and mice. Our results indicate that suppressive ODN down-regulate at both the transcript and protein levels of several proinflammatory cytokines and chemokines as well as nitric oxide and co-stimulatory surface marker molecules when administrated prior to, simultaneously with, or even after LPS challenge, thereby significantly reducing ocular inflammation in both rabbit and mouse eyes. These findings strongly suggest that suppressive ODN is a potent candidate for the prevention of uveitis and could be applied as a novel DNA-based immunoregulatory agent to control other autoimmune or autoinflammatory diseases. © 2010 by The American Society for Biochemistry and Molecular Biology, Inc.en_US
dc.description.provenanceMade available in DSpace on 2016-02-08T09:57:03Z (GMT). No. of bitstreams: 1 bilkent-research-paper.pdf: 70227 bytes, checksum: 26e812c6f5156f83f0e77b261a471b5a (MD5) Previous issue date: 2010en
dc.identifier.doi10.1074/jbc.M110.125948en_US
dc.identifier.issn0021-9258
dc.identifier.urihttp://hdl.handle.net/11693/22217
dc.language.isoEnglishen_US
dc.publisherAmerican Society for Biochemistry and Molecular Biology Inc.en_US
dc.relation.isversionofhttp://dx.doi.org/10.1074/jbc.M1http://dx.doi.org/10.125948en_US
dc.source.titleJournal of Biological Chemistryen_US
dc.subjectDNAen_US
dc.subjectGenesen_US
dc.subjectMammalsen_US
dc.subjectNitric oxideen_US
dc.subjectPathologyen_US
dc.titleMammalian telomeric DNA suppresses endotoxin-induced uveitisen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Mammalian telomeric DNA suppresses endotoxin-induced uveitis.pdf
Size:
572.01 KB
Format:
Adobe Portable Document Format
Description:
Full printable version